Form 4 for SBFM Sunshine Biopharma Inc.
Accepted 2022-02-22 00:00:00 ET · period of report 2022-02-18 · accession 0001683168-22-001185 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-22 | 2022-02-18 | SBFM | Slilaty Steve N. | CEO, Dir | D - Sale to Iss | $0.1 | -990.0K | 10.0K | -99% | -$99.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series B Preferred Stock | 2022-02-18 | D | D | 990,000 | $0.1 | 10,000 | D | — | — |